Michael Krachon - IsoRay Vice President, Director of Sales and Marketing
| ISRDelisted Stock | USD 0.38 0.01 2.70% |
President
Mr. Michael Krachon is Vice President, Director of Sales and Marketing IsoRay, Inc., since March 2016. Mr. Krachon was employed by C.R. Bard Inc. since 2001, and was a key member of the Bard Urological and Medical Division which developed brachytherapy devices and delivery systems for the U.S. and international markets. He was the leader of the brachytherapy commercial team, which grew to be the global brachytherapy market leader. Mr. Krachon assisted in the business units strategic planning, development of the international business segment and creating and delivering the international product launches which resulted in market leadership across Europe, Japan and Africa. His responsibilities included the development of strategic brachytherapy sales and marketing programs the implementation of industry leading national and international training programs and supporting the product development process. Finally, Mr. Krachon was instrumental in successfully supporting the industry through congressional lobbying efforts to establish and maintain reimbursement codes for brachytherapy. He served as Chairman of the Coalition for Advancement of Brachytherapy from 2009 to 2016 and was recognized as a national speaker for brachytherapy by the industry since 2020.
| Age | 47 |
| Tenure | 4 years |
| Professional Marks | MBA |
| Phone | 509 375 1202 |
| Web | https://isoray.com |
IsoRay Management Efficiency
The company has Return on Asset of (0.1085) % which means that on every $100 spent on assets, it lost $0.1085. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1741) %, meaning that it generated no profit with money invested by stockholders. IsoRay's management efficiency ratios could be used to measure how well IsoRay manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Jaime Fernandez | Volaris | 55 | |
| Mark Shaw | Southwest Airlines | 61 | |
| Thomas McGowan | Kite Realty Group | 59 | |
| William Conkling | Summit Hotel Properties | 48 | |
| Carolyn Prowse | Volaris | 46 | |
| Bryan McCarthy | Kite Realty Group | N/A | |
| Paul Ruiz | Summit Hotel Properties | 58 | |
| Robert Jordan | Southwest Airlines | 63 | |
| Holger Blankenstein | Volaris | 49 | |
| Alan Kasher | Southwest Airlines | N/A | |
| Andrea Schneider | Alaska Air Group | 59 | |
| Shane Tackett | Alaska Air Group | 45 | |
| Kyle Levine | Alaska Air Group | 52 | |
| Andrew Watterson | Southwest Airlines | 57 | |
| Scott Murray | Kite Realty Group | 46 | |
| Dave Buell | Kite Realty Group | 36 | |
| Tal Cohen | Nasdaq Inc | 51 | |
| Gregory Wells | Southwest Airlines | 60 | |
| P Griggs | Nasdaq Inc | 53 | |
| Christopher Berry | Alaska Air Group | 39 | |
| Tammy Romo | Southwest Airlines | 62 | |
Management Performance
| Return On Equity | -0.17 | |||
| Return On Asset | -0.11 |
IsoRay Inc Leadership Team
Elected by the shareholders, the IsoRay's board of directors comprises two types of representatives: IsoRay inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IsoRay. The board's role is to monitor IsoRay's management team and ensure that shareholders' interests are well served. IsoRay's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IsoRay's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Austin, Principal Accounting Officer, Co-Principal Financial Officer, Controller | ||
| Alan Hoffmann, Independent Director | ||
| Lisa Lauer, Vice President - Business Development | ||
| Lori Woods, Interim Chief Executive Officer, Director | ||
| Michael McCormick, Independent Chairman of the Board | ||
| Jonathan Hunt, Chief Financial Officer, Co-Principal Financial Officer | ||
| William Cavanagh, Vice President - Research and Development | ||
| Lori HolmesWoods, CEO Director | ||
| Michael Krachon, Vice President, Director of Sales and Marketing | ||
| Jennifer Streeter, Interim Chief Operating Officer, Vice President of Human Resources | ||
| Mark CPA, Controller, Fin | ||
| William III, Chief Officer | ||
| Philip Vitale, Independent Director | ||
| Krista Cline, Senior Director of Operations, Corporate Secretary |
IsoRay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IsoRay a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.17 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (1.16) % | |||
| Operating Margin | (1.21) % | |||
| Current Valuation | (11.02 M) | |||
| Shares Outstanding | 278.66 M | |||
| Shares Owned By Insiders | 0.76 % | |||
| Shares Owned By Institutions | 6.18 % | |||
| Number Of Shares Shorted | 409.25 K | |||
| Price To Earning | (5.00) X |
Pair Trading with IsoRay
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IsoRay position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IsoRay will appreciate offsetting losses from the drop in the long position's value.Moving against IsoRay Stock
| 0.62 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.61 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.58 | PBCRY | Bank Central Asia | PairCorr |
| 0.52 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.5 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to IsoRay could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IsoRay when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IsoRay - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IsoRay Inc to buy it.
The correlation of IsoRay is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IsoRay moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if IsoRay Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IsoRay can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in IsoRay Stock
If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |